Ep. 38: Why A Mini-Correction Would Be Healthy With Patrick Healey
About this episode
Patrick Healey, founder of Caliber Financial Partners, joined the podcast this week to discuss how a mini-correction would be healthy for the current stock market and how to manage investment FOMO (fear of missing out). Plus, we take a look at three stocks: Amarin (AMRN), Acadia Pharmaceuticals (ACAD) and Ventas (VTR). For the video version, show notes and charts, visit investors.com/podcast.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Investing With IBD publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Investing With IBD
Is A Market Pivot Ahead? Key Moves For A September Shift
Investing With IBD
Monster Moves, Long-Term Trends And Wisdom For Your Portfolio
Investing With IBD
Measure It And Protect It. Indicators You Can Use To Defend Your Portfolio.
Investing With IBD
How To Use This Key Indicator As A Measure Of Stability
Investing With IBD